Biopharma

Trump signs order to expand IVF by making it more affor...

According to a fact sheet provided by the White House, Trump's IVF order will fo...

Bavarian Nordic catches up to rival Valneva with broad ...

Valneva may have won the chikungunya vaccine race with its world-first approval,...

Novo Nordisk to sue KBP Biosciences over alleged fraudu...

After its potential kidney disease drug went down in flames late last year, Novo...

Trump administration layoffs hit FDA's device center

It’s unclear how many staff at the FDA have been affected. There have also been ...

STAT+: Generic drugmakers win a long-running battle wit...

A judge in California has ruled that a law banning so-called pay-to-delay deals ...

Trump administration layoffs hit FDA’s device center

It’s unclear how many staff at the FDA have been affected. There have also been ...

Opinion: The ‘disease detectives’ dodged a bullet — but...

“While the EIS program has likely been spared this time, the fact that its exist...

STAT+: FDA’s former top food official says Trump firing...

The former head of the FDA's food division told STAT he resigned because cuts ma...

As BMS-paired triplet misses survival mark in kidney ca...

While Exelixis has abandoned a plan to seek an FDA approval for a combination of...

AstraZeneca hit with US class action lawsuit over China...

Lawsuit claims UK pharma giant understated the risk of government investigations

Opinion: Former CDC director: Two programs reportedly o...

Former CDC Director Tom Frieden warns that cutting the Public Health Associate P...

Testosterone Recovery Linked to Overall Survival in Hig...

TUESDAY, Feb. 18, 2025 -- Serum testosterone (T) recovery to normal levels is a...

Exercise Regimen Can Improve Fatigue in Patients With A...

TUESDAY, Feb. 18, 2025 -- For patients with advanced prostate cancer (aPC), com...

ASA: Alteplase Ups Outcomes at 4.5 to 24 Hours After Sy...

TUESDAY, Feb. 18, 2025 -- For patients with acute ischemic stroke (AIS) whose s...

Mobile Prostate Cancer Screening Clinic Can ID the Dise...

TUESDAY, Feb. 18, 2025 -- A "Man Van" deployed in disadvantaged communities can...

ASA: Intra-Arterial Tenecteplase Beneficial for Large V...

TUESDAY, Feb. 18, 2025 -- For patients with large vessel occlusion presenting b...

2019 to 2020 Saw 17.9 Percent Decrease in Ophthalmic Pr...

TUESDAY, Feb. 18, 2025 -- There was a notable decrease in common ophthalmic pro...

FDA Approves Tablet Form of Evrysdi for Spinal Muscular...

TUESDAY, Feb. 18, 2025 -- The U.S. Food and Drug Administration has approved a ...

Guidance Provided for PCPs to Identify Biliary Atresia ...

TUESDAY, Feb. 18, 2025 -- In a clinical report issued by the American Academy o...

Biogen buys rights to Stoke’s rare epilepsy drug

In exchange for $165 million, Biogen now has access to zorevunersen, a potential...

FDA signs off on Sanofi's insulin biosimilar, the first...

The FDA has given a thumbs up to Sanofi’s Merilog as the first biosimilar substi...

Solid says early data suggest ‘differentiated’ Duchenne...

The company raised $200 million after early findings hinted its therapy could be...

Uganda discharges the last Ebola patients. No new death...

Uganda discharged on Tuesday the last eight patients who recovered from Ebola, a...

2 NIH leaders depart as White House cuts thousands of j...

The National Institutes of Health has lost two distinguished leaders as mass lay...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.